Kura Oncology Doses First Patient in Phase 1 Clinical Trial of Menin-MLL Inhibitor KO-539 in Acute Myeloid Leukemia

September 16, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search